Efficacy and Safety of Stempeucel ® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

Conditions:   Critical Limb Ischemia;   Buerger's Disease Intervention:   Biological: Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells Sponsors:   Cell Biopeutics Resources Sdn Bhd;   Stempeutics Research Pvt Ltd;   National University of Malaysia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials